Viewing Study NCT01646450


Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2026-01-23 @ 5:49 PM
Study NCT ID: NCT01646450
Status: UNKNOWN
Last Update Posted: 2015-09-09
First Post: 2012-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients
Sponsor: Betta Pharmaceuticals Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module